San Diego, CA -- (SBWire) -- 10/27/2021 --Organogenesis Holdings Inc is under investigation concerning potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Organogenesis Holdings Inc. (NASDAQ: ORGO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on whether a series of statements by Organogenesis Holdings Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Canton, MA based Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. On October 12, 2021, Value Investors Club issued a report alleging issues at Organogenesis Holdings, Inc., indicating that the wound care medical company has been improperly billing the federal government for $250 million annually. Organogenesis Holdings Inc. also set the price for its new wound covering, Affinity, "exorbitantly high", which Medicare reimbursed, while making the product lucrative for doctors to use through large rebates. Shares of Organogenesis Holdings Inc. (NASDAQ: ORGO) declined from $17.00 per share on September 22, 2021, to $9.57 per share on October 12, 2021.
Those who purchased shares of Organogenesis Holdings Inc. (NASDAQ: ORGO) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NASDAQ:ORGO Shareholder Notice: Investigation over Possible Securities Laws Violations by Organogenesis Holdings Inc.
An investigation for investors in Organogenesis Holdings Inc. (NASDAQ:ORGO) shares over potential securities laws violations by Organogenesis Holdings Inc. was announced.